Monoclonal gammopathy of undetermined significance and solitary plasmacytoma: Implications for progression to overt multiple myeloma

Hematology/Oncology Clinics of North America

Volumn 11, Issue 1, 1997, Pages 71-87

  Kyle, R A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURVIVAL; CARCINOGENESIS; HUMAN; MACROGLOBULINEMIA; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PLASMA CELL; PLASMACYTOMA; PRIORITY JOURNAL; REVIEW;

EID: 0030984530     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70416-0     Document Type: Article

References (54)

1. U. Axelsson A 20-year follow-up study of 64 subjects with M-components Acta Med Scand 219 1986 519
2. U. Axelsson R. Bachmann J. Ha¨lle´n Frequency of pathological proteins (M-components) in 6,995 sera from an adult population Acta Med Scand 179 1966 235
3. L. Baldini A. Guffanti B.M. Cesana Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy Blood 87 1996 912
4. R. Bataille D. Chappard Basle M.-F. Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: A prospective study of 87 bone biopsies Blood 87 1996 4762
5. R. Bataille D. Chappard B. Klein Mechanisms of bone lesions in multiple myeloma Hematol Oncol Clin North Am 6 1992 285
6. R. Bataille M. Jourdan X.G. Zhang Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias J Clin Invest 84 1989 2008
7. R. Bataille J. Sany Solitary myeloma: Clinical and prognostic features of a review of 114 cases Cancer 48 1981 845
8. J. Blade´ A. Lo´pez-Guillermo C. Rozman Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance Br J Haematol 81 1992 391
9. M. Bowden J. Crawford H.J. Cohen A comparative study of monoclonal gammopathies and immunoglobulin levels in Japanese and United States elderly J Am Geriatr Soc 41 1993 11
10. M. Burt M. Karpeh O. Ukoha Medical tumors of the chest wall. Solitary plasmacytoma and Ewing's sarcoma J Thorac Cardiovasc Surg 105 1993 89
11. A. Carter I. Tatarsky The physiopathological significance of benign monoclonal gammopathy: A study of 64 cases Br J Haematol 46 1980 565
12. J. Crawford M.K. Eye H.J. Cohen Evaluation of monoclonal gammopathies in the “well” elderly Am J Med 82 1987 39
13. M.A. Dimopoulos J. Goldstein L. Fuller Curability of solitary bone plasmacytoma J Clin Oncol 10 1992 587
14. J. Drach J. Angerler J. Schuster Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance Blood 86 1995 3915
15. P.A. Ellis B.M. Colls Solitary plasmacytoma of bone: Clinical features, treatment and survival Hematol Oncol 10 1992 207
16. T. Facon J.F. Menard J.L. Michaux Prognostic factors in low tumour mass asymptomatic multiple myeloma: A report on 91 patients Am J Hematol 48 1995 71
17. J.M. Fine P. Lambin J.Y. Muller The evolution of asymptomatic monoclonal gammopathies. A follow-up of 20 cases over periods of 3–14 years Acta Med Scand 205 1979 339
18. D.A. Frassica F.J. Frassica M.F. Schray Solitary plasmacytoma of bone: Mayo Clinic experience Int J Radiat Oncol Biol Phys 16 1989 43
19. H. Garewal B.G. Durie R.A. Kyle Serum beta 2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders J Clin Oncol 2 1984 51
20. M.P. Giraldo D. Rubio-Fe´lix M. Perella Gammapati´as monoclonales de significado indeterminado. Aspectos cli´nicos, biolo´gicos y evolutivos de 397 casos Sangre (Barc) 36 377 1991
21. N.J. Gonchoroff P.R. Greipp R.A. Kyle A monoclonal antibody reactive with 5-bromo-2-deoxyuridine that does not require DNA denaturation Cytometry 6 1985 506
22. J. Holland D.A. Trenkner T.H. Wasserman Plasmacytoma. Treatment results and conversion to myeloma Cancer 69 1992 1513
23. E. Isaksson M. Bjo¨rkholm G. Holm Blood clonal B-cell excess in patients with monoclonal gammopathy of undetermined significance (MGUS): Association with malignant transformation Br J Haematol 92 1996 71
24. A. Jackson J.H. Scarffe Upper humeral cortical thickness as an indicator of osteopenia: Diagnostic significance in solitary myeloma of bone Skeletal Radiol 20 1991 363
25. M.A. Knowling A.R. Harwood D.E. Bergsagel Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone J Clin Oncol 1 1983 255
26. R.A. Kyle Monoclonal gammopathy of undetermined significance. Natural history in 241 cases Am J Med 64 1978 814
27. R.A. Kyle `Benign' monoclonal gammopathy: A misnomer? JAMA 251 1984 1849
28. R.A. Kyle “Benign” monoclonal gammopathy—after 20 to 35 years of follow-up Mayo Clin Proc 68 1993 26
29. R.A. Kyle The monoclonal gammopathies Clin Chem 40 1994 2154
30. R.A. Kyle J.A. Lust Monoclonal gammopathies of undetermined significance ed 2 Wiernik P.H. Canellos G.P. Kyle R.A. Neoplastic Diseases of the Blood 1991 Churchill Livingstone New York 571
31. R.A. Kyle S. Finkelstein L.R. Elveback Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma Blood 40 1972 719
32. R.A. Kyle C.M. Beard W.M. O'Fallon Incidence of multiple myeloma in Olmsted County, Minnesota: 1978 through 1990, with a review of the trend since 1945 J Clin Oncol 12 1994 1577
33. G.J. Ligthart J. Radl J.X. Corberand Monoclonal gammopathies in human aging: Increased occurrence with age and correlation with health status Mech Ageing Dev 52 1990 235
34. F.D. Lindstro¨m U. Dahlstro¨m Multiple myeloma or benign monoclonal gammopathy? A study of differential diagnostic criteria in 44 cases Clin Immunol Immunopathol 10 1978 168
35. Malacrida V. De Francesco D. G. Banfi Laboratory investigation of monoclonal gammopathy during 10 years of screening in a general hospital J Clin Pathol 40 1987 793
36. R.F. McLain J.N. Weinstein Solitary plasmacytomas of the spine: A review of 84 cases Journal of Spinal Disorders 2 1989 69
37. A. Miguel-Garcia E. Matutes F. Tarin Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy J Clin Pathol 48 1995 835
38. J. Møller-Petersen E.B. Schmidt Diagnostic value of the concentration of M-component in initial classification of monoclonal gammopathy Scand J Haematol 36 1986 295
39. L.A. Moulopoulos M.A. Dimopoulos D. Weber Magnetic resonance imaging in the staging of solitary plasmacytoma of bone J Clin Oncol 11 1993 1311
40. F. Ong U. Kaiser P.J. Seelen Serum neural cell adhesion molecule differentiates multiple myeloma from paraproteinemias due to other causes Blood 87 1996 712
41. G. Paladini M. Fogher G. Mazzanti Gammopatia monoclonale idiopatica. Studio a lungo termine di 313 casi Recenti Prog Med 80 1989 123
42. Pelliniemi T.-T. K. Iriala K. Mattila Serum immunoreactive interleukin-6 (IL6) and acute phase proteins as prognostic factors in multiple myeloma (MM) [abstract] Blood 82 suppl 1 1993 262a
43. S. Peltonen C. Wasastjerna O. Wager Clinical features of patients with a serum M component Acta Med Scand 203 1978 257
44. J.P. Saleun M. Vicariot P. Deroff Monoclonal gammopathies in the adult population of Finiste`re, France J Clin Pathol 35 1982 63
45. G.P. Schechter N. Shoff C. Chan The frequency of monoclonal gammopathy of undetermined significance (MGUS) in black and Caucasian veterans in a hospital population (abstract) Blood 76 suppl 1 1990 371a
46. L.Y. Shih P. Dunn W.M. Leung Localised plasmacytomas in Taiwan: Comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone Br J Cancer 71 1995 128
47. Singh J. Dudley A.W. Jr K.A. Kulig Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting J Lab Clin Med 116 1990 785
48. P. Sonneveld B.G. Durie H.M. Lokhorst Analysis of multidrug-resistance (MDR-1) glycoprotein and CD56 expression to separate monoclonal gammopathy from multiple myeloma Br J Haematol 83 1993 63
49. van de Poel M.H. J.W. Coebergh H.F. Hillen Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in southeastern Netherlands Br J Haematol 91 1995 121
50. A.O. Vladutiu Prevalence of M-proteins in serum of hospitalized patients. Physicians' response to finding M-proteins in serum protein electrophoresis Ann Clin Lab Sci 17 1987 157
51. T.E. Witzig N.J. Gonchoroff J.A. Katzmann Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies J Clin Oncol 6 1988 1041
52. T.E. Witzig R.A. Kyle W.M. O'Fallon Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma Br J Haematol 87 1994 266
53. M. Zandecki V. Obein F. Bernardi Monoclonal gammopathy of undetermined significance: Chromosome changes are a common finding within bone marrow plasma cells Br J Haematol 90 1995 693
54. X.G. Zhang R. Bataille J. Widjenes Interleukin-6 dependence of advanced malignant plasma cell dyscrasias Cancer 69 1992 1373